The US subsidiary of Ranbaxy Laboratories, India’s biggest pharmaceuticals group, has pleaded guilty to felony charges related to drug safety and will pay $500m in what the US Department of Justice called the largest such settlement to date with a generic drug manufacturer.
It lifts a cloud hanging over Ranbaxy for the past eight years. But it is still not clear when the company will be able to resume exports to the US from its two factories at the centre of the scandal, which have been at a virtual standstill since 2008. Continue reading »
By Sudip Chaudhuri of the Indian Institute of Management, Calcutta
While foreign governments cheered loudly in favour of Felipe Calderón’s war against Mexico’s drug gangs, Jorge Castañeda always maintained it was unwinnable, a “bloody, reckless adventure”.
Stefan Wagstyl
Rob Minto
Pan Kwan Yuk
Jonathan Wheatley
Heba Saleh